| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects
|
Sun, Lei
|
|
2019
|
39 |
5 |
p. 477-484
|
artikel
|
| 2 |
Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review
|
Lee, Young R.
|
|
2019
|
39 |
5 |
p. 429-440
|
artikel
|
| 3 |
Chronic Use of β-Blockers and the Risk of Parkinson’s Disease
|
Koren, Gideon
|
|
2019
|
39 |
5 |
p. 463-468
|
artikel
|
| 4 |
Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
|
Song, Gwan Gyu
|
|
2019
|
39 |
5 |
p. 421-428
|
artikel
|
| 5 |
Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
|
Wrishko, Rebecca E.
|
|
2019
|
39 |
5 |
p. 453-454
|
artikel
|
| 6 |
Early Treatment of Systemic Juvenile Idiopathic Arthritis with Canakinumab and Complete Remission After 2 Years of Treatment Suspension: Case Report of an Adolescent Girl
|
Maggio, Maria Cristina
|
|
2019
|
39 |
5 |
p. 491-494
|
artikel
|
| 7 |
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
|
Wrishko, Rebecca E.
|
|
|
39 |
5 |
p. 441-451
|
artikel
|
| 8 |
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
|
Wrishko, Rebecca E.
|
|
|
39 |
5 |
p. 441-451
|
artikel
|
| 9 |
Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis
|
Lombardi, Niccolò
|
|
2019
|
39 |
5 |
p. 455-462
|
artikel
|
| 10 |
The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?
|
Hommers, Leif
|
|
2019
|
39 |
5 |
p. 485-489
|
artikel
|
| 11 |
Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes Mellitus
|
Kaneko, Masayuki
|
|
2019
|
39 |
5 |
p. 469-476
|
artikel
|
Tijdschrift beschrijving